Congressionally Directed Medical Research Programs

Congressionally Directed Medical Research Programs

Overview

The Congressionally Directed Medical Research Programs (CDMRP) are a U.S. Department of Defense program that funds innovative and impactful biomedical research. Established in 1992, the CDMRP is directed by Congress to target specific diseases, conditions, and injuries, with a focus on projects that are high-impact, high-risk, and high-gain that other agencies might not fund. The program supports the full pipeline of research from basic to clinical and aims to find and fund solutions that will lead to cures, improvements in patient care, or breakthrough technologies for Service Members, Veterans, and the American public. The U.S. Army Medical Research and Development Command (USAMRDC) administers the program.

Portfolio Companies

7

Investments

CompanyDateStageLead
Rivanna MedicalOct 2025GrantLead
VascudyneJun 2025GrantCo-investor
pacDNAJan 2025GrantCo-investor
Roam RoboticsAug 2024GrantCo-investor
Gel4MedMay 2024GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMaryland
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.